123 related articles for article (PubMed ID: 6474452)
1. Effect of niceritrol on lipid metabolism of aorta in atherosclerotic rats.
Shirai K; Ishikawa Y; Nishide T; Sasaki N; Murano S; Sato A; Matsuoka N; Saito Y; Yoshida S
Tohoku J Exp Med; 1984 Jun; 143(2):231-8. PubMed ID: 6474452
[TBL] [Abstract][Full Text] [Related]
2. Effect of clinofibrate on lipid metabolism of aorta in atherosclerotic rats.
Shirai K; Ishikawa Y; Nishide T; Sasaki N; Murano S; Matsuoka N; Saito Y; Yoshida S
Artery; 1983; 12(3):145-55. PubMed ID: 6680996
[TBL] [Abstract][Full Text] [Related]
3. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
4. Action of niceritrol (pentaerythritoltetranicotinate) on lipid accumulation in aortas of cholesterol-fed rabbits independent of contemporary reduction of serum lipids.
Brattsand R; Petersen H; Lundholm L
Atherosclerosis; 1974; 20(3):469-79. PubMed ID: 4373018
[No Abstract] [Full Text] [Related]
5. Actions of vitamins A and E and some nicotinic acid derivatives on plasma lipids and on lipid infiltration of aorta in cholesterol-fed rabbits.
Brattsand R
Atherosclerosis; 1975; 22(1):47-61. PubMed ID: 1156470
[TBL] [Abstract][Full Text] [Related]
6. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Vessby B; Lithell H; Gustafsson IB; Borberg J
Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
[TBL] [Abstract][Full Text] [Related]
7. A nicotinic acid ester and experimental atherosclerosis: no significant effect of treatment with niceritrol (pentaerythritoltetranicotinate) on cholesterol in aorta of rabbits previously fed with cholesterol-enriched diet.
Stender S; Astrup P; Brattsand R
Atherosclerosis; 1976; 23(3):503-11. PubMed ID: 1267865
[TBL] [Abstract][Full Text] [Related]
8. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
[TBL] [Abstract][Full Text] [Related]
9. Lipid metabolism in arteriosclerotic arterial wall of rats.
Morisaki N; Murano S; Shinomiya M; Sasaki N; Shirai K; Matsuoka N; Mizobuchi M; Akikusa B; Saito Y; Kumagai A
Atherosclerosis; 1982 May; 43(1):51-7. PubMed ID: 7092982
[TBL] [Abstract][Full Text] [Related]
10. Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
Vessby B; Lithell H; Gustafsson IB; Boberg J
Atherosclerosis; 1980 Jan; 35(1):51-65. PubMed ID: 6989377
[TBL] [Abstract][Full Text] [Related]
11. Pentaerythritol tetranicotinate (niceritrol) decreases plasma lipoprotein(a) levels.
Tanaka K; Hayashi K; Shingu T; Kuga Y; Okura Y; Yasunobu Y; Ohtani H; Nomura S; Kurushima H; Saeki M; Kambe M; Kajiyama G
Metabolism; 1997 Apr; 46(4):355-8. PubMed ID: 9109834
[TBL] [Abstract][Full Text] [Related]
12. Clinical study of niceritrol on serum lipids in the treatment of hyperlipidemia.
Kibata M; Ishida M; Asano K; Uehara H; Saito K; Fuchimoto T; Ugaki K; Murakami H; Matoba K; Kotakemori Y; Shirai K; Yoshioka H; Nanba M; Yasuda M; Ishizaki M; Kitagawa N; Ikejiri K; Inohara R; Lee BJ; Saino S; Sakado J; Matuzaka H; Numata K; Mandai M; Miyake K; Nakamura K
Atherosclerosis; 1980 Nov; 37(3):333-42. PubMed ID: 7458980
[TBL] [Abstract][Full Text] [Related]
13. Folic acid and lipoprotein lipase from aorta and blood plasma of atherosclerotic rats.
Povoa H; Marcondes N; Fernandes L; Vicente MM
Biomed Biochim Acta; 1984; 43(2):241-4. PubMed ID: 6732760
[TBL] [Abstract][Full Text] [Related]
14. Effect of trifluoperazine on certain arterial wall lipid-metabolizing enzymes inducing atherosclerosis in rhesus monkeys.
Mohindroo A; Ahluwalia P
Lipids; 1997 Aug; 32(8):867-72. PubMed ID: 9270979
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig.
Bocan TM; Mueller SB; Uhlendorf PD; Brown EQ; Mazur MJ; Black AE
Atherosclerosis; 1993 Mar; 99(2):175-86. PubMed ID: 8503946
[TBL] [Abstract][Full Text] [Related]
16. The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.
Nagakawa Y; Orimo H; Harasawa M
Thromb Res; 1985 Nov; 40(4):543-53. PubMed ID: 4082125
[TBL] [Abstract][Full Text] [Related]
17. The effect of niceritrol (pentaerythritoltetranicotinate) and clofibrate upon hyperlipemia and atherosclerosis induced in rabbits by cholesterol-free semisynthetic diets.
Brattsand R
Atherosclerosis; 1974; 20(3):453-67. PubMed ID: 4373017
[No Abstract] [Full Text] [Related]
18. Regression of atherosclerotic lesions and control of plasma lipids and lipoprotein cholesterol by Anna Pavala Sindhooram therapy.
Dhandapani K; Iyer RB; Kareem MA; Shanmugasundaram KR
Pharmacol Res Commun; 1984 Aug; 16(8):737-54. PubMed ID: 6494218
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
